FREE SHIPPING ON ORDERS OVER $150

ovarian cancer and glutathione Transferase P1: Potential Therapeutic Target in Multi-Omics Analysis Reveals Chronic Cisplatin

$22.78

Quantity
- +
Description

It is an experimental compound not approved for human clinical use

ovarian cancer and glutathione Transferase P1: Potential Therapeutic Target in Multi-Omics Analysis Reveals Chronic Cisplatin

Standard free energy maps for the hydrolysis of ATP as a function of pH, pMg and pCa

ovarian cancer and glutathione Transferase P1: Potential Therapeutic Target in Multi-Omics Analysis Reveals Chronic Cisplatin

During metabolism the most uncertain point is how GABA enters the mitochondrion

ovarian cancer and glutathione Transferase P1: Potential Therapeutic Target in Multi-Omics Analysis Reveals Chronic Cisplatin

Excitotoxic concentrations of the neurotransmitter glutamate lead to stimulation of N-methyl-D-aspartate (NMDA) receptor activity resulting in an increase of intracellular cation (such as Ca2+) levels, and finally to mitochondrial dysfunction (30)

ovarian cancer and glutathione Transferase P1: Potential Therapeutic Target in Multi-Omics Analysis Reveals Chronic Cisplatin

Chen S, Xu L, Lin N, Pan W, Hu K, Xu R

ovarian cancer and glutathione Transferase P1: Potential Therapeutic Target in Multi-Omics Analysis Reveals Chronic Cisplatin

How Does B12 Affect Inflammation

ovarian cancer and glutathione Transferase P1: Potential Therapeutic Target in Multi-Omics Analysis Reveals Chronic Cisplatin

You may also like

Venature

US$ 29.70

4.8 (16 reviews)

recommand products